NCT03570021 2026-03-06
ESTIMABL3
Gustave Roussy, Cancer Campus, Grand Paris
Phase 3 Active not recruiting
Clinical Trials
8 trialsNCT06554652 2026-02-27
Selective Neck Dissection Versus Modified Neck Dissection in PTC
Fudan University
Phase 3 Recruiting
NCT06558981 2026-02-27
Adjuvant Radiotherapy in High Risk Locally Advanced DTC
Fudan University
Phase 3 Recruiting
NCT06860971 2025-12-31
A Study of AL2846 Capsule Versus Placebo in the Treatment of Advanced Radioiodine-Refractory Differentiated Thyroid Carcinoma
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Phase 3 Recruiting
NCT05999630 2025-10-28
Artificial Tears to Prevent Nasolacrimal Duct Obstruction in Patients Treated With Radioactive Iodine for Thyroid Cancer
Vanderbilt University Medical Center
Phase 3 Recruiting
NCT04290663 2025-10-14
INTERMEDIATE
Centre Francois Baclesse
Phase 3 Recruiting
NCT03690388 2025-09-25
A Study of Cabozantinib Compared With Placebo in Subjects With Radioiodine-refractory Differentiated Thyroid Cancer Who Have Progressed After Prior Vascular Endothelial Growth Factor Receptor (VEGFR) -Targeted Therapy
Exelixis
Phase 3 Active not recruiting
NCT00410761 2025-09-24
An Efficacy Study Comparing ZD6474 to Placebo in Medullary Thyroid Cancer
Sanofi
Phase 3 Completed